LABU ETF — Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares (LABU)

LABU is an ETF that tracks the S&P Biotechnology Select Industry Index. As of August 28, 2026, its distribution rate is 0.07%, its trailing-12-month yield is 0.34%, its expense ratio is 0.96%. Dividend Vision Distribution Safety Score™ is 19/100 (High risk). Fund total return is -90.3% over the past 11.3 years, 426.8 points behind SPY at 336.5%.

At the current 0.07% distribution rate, a $10,000 investment would generate approximately $7 per year, or $0.58 per month on an equivalent basis. Actual quarterly payments vary.

Direxion Daily S&P Biotech Bull 3X Shares is an ETF that seeks to deliver three times the daily performance of the S&P Biotechnology Select Industry Index through leveraged exposure via swap agreements, index securities, and related ETFs. The fund carries a high expense ratio and distributes quarterly at a modest rate. It appeals to experienced traders and investors seeking amplified short-term exposure to the biotechnology sector, though the daily rebalancing and leverage introduce elevated volatility and complexity unsuitable for typical buy-and-hold investors.

LABU performance versus SPY

Data as of August 28, 2026.

Fund total return is -90.3% over the past 11.3 years, 426.8 points behind SPY at 336.5%. Its deepest 1-year drawdown was 30.7%.

LABU key facts

Data as of August 28, 2026.

Distribution Safety Score™

19 · High risk

Safety-Adjusted Yield

0.01%

Issuer

Direxion

Asset type

ETF

Asset class

Equity

Inception date

05/28/2015

Expense ratio

0.96%

Distribution rate

0.07%

Distribution frequency

Quarterly

Trailing yield

0.34%

Last close

$295.76

AUM

$663,403,154

Average volume

528702.0

Last dividend

$0.9100

Ex-dividend date

12/23/2025

Payment date

12/31/2025

Beta

3.26

How Dividend Vision calculates yield and returns

Distribution rate (0.07%) is the latest regular payout annualized by the fund's stated frequency, divided by the last close. Issuers often publish this as “Distribution Rate” on the fact sheet. Trailing-12-month yield (0.34%) is the sum of distributions paid in the last 12 months, split-adjusted, divided by the last close. It lags a recent raise or cut. We show a 30-day SEC yield when the fund publishes one. Schwab and other issuers may report a TTM distribution yield or SEC yield on a different date — all can be valid; they are not interchangeable. Fund total return uses split-adjusted close with distributions reinvested from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is what the fund did, not your personal gain/loss. Figures below use Dividend Vision data as of August 28, 2026.

Distribution rate methodology · Distribution Safety Score methodology · SEC yield

Sources and review

Data as of August 28, 2026.

Primary sources: Direxion fund page; Index: S&P Biotechnology Select Industry Index; prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

LABU risks and drawbacks

LABU's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Payments are quarterly, so cash flow is lumpy versus a monthly fund. Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 30.7%.

Who may consider LABU — and who may not

It is a weaker fit for investors who need monthly cash flow (LABU pays quarterly); investors hunting double-digit covered-call yields; investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

Frequently asked questions

More funds from Direxion.